CAPTRUST FINANCIAL ADVISORS - HIKMA PHARMACEUTICALS PLC SHS ownership

Back to all holdings Add to watchlist

HIKMA PHARMACEUTICALS PLC SHS's ticker is and the CUSIP is G4576K104. A total of 1 filers reported holding HIKMA PHARMACEUTICALS PLC SHS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of HIKMA PHARMACEUTICALS PLC SHS
ValueSharesWeighting
Q2 2022$14,000
-26.3%
7160.0%0.00%–
Q1 2022$19,000–716–0.00%–
 Download
Other shareholders
HIKMA PHARMACEUTICALS PLC SHS shareholders Q1 2022
NameSharesValueWeighting ↓
CAPTRUST FINANCIAL ADVISORS 716$19,0000.00%
View complete list of HIKMA PHARMACEUTICALS PLC SHS shareholders